The role of economic evaluation in infection control

American Journal of Infection Control

Volumn 29, Issue 5, 2001, Pages 338-344

  Saint, Sanjay ^a   Chenoweth, Carol ^b   Fendrick, A Mark ^a,c,d  

^a Division of Infectious Diseases   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c Consortium for Health Outcomes Innovation and Cost Effectiveness Studies ^*  (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH ECONOMICS; INFECTION CONTROL; MEDICAL DECISION MAKING; META ANALYSIS;

EID: 0034793745     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2001.115819     Document Type: Article

References (26)

1. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: A consensus panel report - Society for Healthcare Epidemiology of America
2. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: An empirical determination from a nationally representative sample
3. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection
4. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection
5. Evaluation of suspected urinary tract infection in ambulatory women: A cost-utility analysis of office-based strategies
6. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada
7. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori
8. Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B
9. The use of meta-analysis in cost-effectiveness analysis: Issues and recommendations
10. Meta-analyses of randomized controlled trials
11. Meta-analysis: Statistical alchemy for the 21st century
12. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis
13. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: A meta-analysis
14. The role of cost-effectiveness analysis in health and medicine: Panel on Cost-Effectiveness in Health and Medicine
15. Predicting survival, length of stay, and cost in the surgical intensive care unit: APACHE II versus ICISS
16. A comparison of the Acute Physiology and Chronic Health Evaluation (APACHE) II score and the Trauma-Injury Severity Score (TRISS) for outcome assessment in intensive care unit trauma patients
17. The use of APACHE III to evaluate ICU length of stay, resource use, and mortality after coronary artery by-pass surgery
18. Preventing catheter-related bacteriuria: Can we? Should we? How?
19. Clinical and economic consequences of nosocomial catheter-related bacteriuria
20. Decision analytic modeling and NSAID gastropathy: Could we be more sensitive?
21. Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach
22. Economic analysis alongside clinical trials. Revisiting the methodological issues
23. The Lowbury Lecture. The economics of nosocomial infections